← back to search

Suneil K. Koliwad

BioSurfaces (United States) · US
Area of research
Physiology · Epidemiology
Research interest
Research interests include Adipose Tissue and Metabolism, Adipokines, Inflammation, and Metabolic Diseases, Regulation of Appetite and Obesity, and Neuroinflammation and Neurodegeneration Mechanisms.
h-index
38
citations
6,666
works
113
NIH funding
primary concept
Medicine
email

Recent publications

Inducible deletion of DGAT1 and 2 from microglia exacerbates neurodegeneration and endolysosomal lipid accumulation in male PS19 mice
Cell Reports 2026cited by 1position: middledoi
Novel Inpatient Automated Self-Adjusting Subcutaneous Insulin Algorithm: 3-Year Experience. An Observational Study.
2026cited by 1position: contributordoi
ApoE-Dependent Lipid Handling by Median Eminence Microglia Preserves Myelin Integrity and Metabolic Function
2026cited by 0position: contributordoi
Osteoprotegerin-Enabled Immune Evasion of Pathological Adipose Stromal Cells Drives Metabolic Dysfunction in Obesity
2026cited by 0position: contributordoi
Twenty-first century management of diabetes with shared telemedicine appointments.
2025cited by 3position: contributordoi
Assessment of Large Language Models for Enhancing Diabetologist-Developed Personalized Treatment Plans in Complex Type 2 Diabetes.
2025cited by 0position: contributordoi
Real-World Type 2 Diabetes Second-Line Treatment Allocation Among Patients
2025cited by 0position: contributordoi
Consensus on the key characteristics of metabolism disruptors
Nature Reviews Endocrinology 2024cited by 44position: middledoi
The Diabetes Technology Society Error Grid and Trend Accuracy Matrix for Glucose Monitors
Journal of Diabetes Science and Technology 2024cited by 34position: middledoi
The Diabetes Technology Society Error Grid and Trend Accuracy Matrix for Glucose Monitors.
2024cited by 28position: contributordoi
Novel Automated Self-adjusting Subcutaneous Insulin Algorithm Improves Glycemic Control and Physician Efficiency in Hospitalized Patients.
2024cited by 5position: contributordoi
A Glycemia Risk Index (GRI) of Hypoglycemia and Hyperglycemia for Continuous Glucose Monitoring Validated by Clinician Ratings.
2023cited by 210position: contributordoi
Obesity-associated microglial inflammatory activation paradoxically improves glucose tolerance
Cell Metabolism 2023cited by 41position: middledoi
Obesogens and Obesity: State-of-the-Science and Future Directions Summary from a Healthy Environment and Endocrine Disruptors Strategies Workshop
American Journal of Clinical Nutrition 2023cited by 25position: middledoi
A Glycemia Risk Index (GRI) of Hypoglycemia and Hyperglycemia for Continuous Glucose Monitoring Validated by Clinician Ratings
Journal of Diabetes Science and Technology 2022cited by 270position: middledoi
The Impact of Insulin Resistance on Loss of Lung Function and Response to Treatment in Asthma
American Journal of Respiratory and Critical Care Medicine 2022cited by 88position: middledoi
Continuous Ketone Monitoring Consensus Report 2021.
2022cited by 35position: contributordoi
Excess natural-cause deaths in California by cause and setting: March 2020 through February 2021
PNAS Nexus 2022cited by 25position: middledoi
Metabolic factors in the regulation of hypothalamic innate immune responses in obesity.
2022cited by 14position: contributordoi
Invariant natural killer T cells coordinate removal of senescent cells
Med 2021cited by 74position: middledoi
The East Asian gut microbiome is distinct from colocalized White subjects and connected to metabolic health
eLife 2021cited by 55position: middledoi
Continuous Ketone Monitoring Consensus Report 2021
Journal of Diabetes Science and Technology 2021cited by 51position: middledoi
Microglial Lipid Biology in the Hypothalamic Regulation of Metabolic Homeostasis
Frontiers in Endocrinology 2021cited by 41position: middledoi
Continuous Ketone Monitoring: A New Paradigm for Physiologic Monitoring.
2021cited by 24position: contributordoi
CD81 Controls Beige Fat Progenitor Cell Growth and Energy Balance via FAK Signaling
Cell 2020cited by 295position: middledoi
Blocking Kv1.3 potassium channels prevents postoperative neuroinflammation and cognitive decline without impairing wound healing in mice
British Journal of Anaesthesia 2020cited by 38position: middledoi
mTORC1-to-AMPK switching underlies β cell metabolic plasticity during maturation and diabetes
Journal of Clinical Investigation 2019cited by 125position: middledoi
mTORC1 to AMPK switching underlies β-cell metabolic plasticity during maturation and diabetes.
2019cited by 103position: contributordoi
Genetic basis for the cooperative bioactivation of plant lignans by Eggerthella lenta and other human gut bacteria
Nature Microbiology 2019cited by 102position: middledoi
Obesity and Fat Metabolism in Human Immunodeficiency Virus–Infected Individuals: Immunopathogenic Mechanisms and Clinical Implications
The Journal of Infectious Diseases 2019cited by 96position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 12 papers (2019–2026)Martín Valdearcos · University of California, San Francisco11 papers (2014–2023)Diana Alba · University of San Francisco5 papers (2018–2021)Megan M. Robblee · University of California, San Francisco4 papers (2014–2023)David C. Klonoff · Mills Peninsula Health Services3 papers (2021–2025)Xiaomei Feng · Xi'an University of Science and Technology3 papers (2017–2020)Mervyn Maze · San Francisco General Hospital3 papers (2017–2020)Daniel R. Stifler · University of California, San Francisco3 papers (2017–2018)Robert V. Farese · Memorial Sloan Kettering Cancer Center3 papers (2012–2018)Shingo Kajimura · Harvard University2 papers (2018–2020)Yosuke Uchida · Hokkaido University2 papers (2017–2020)Kenji Ikeda · Toranomon Hospital2 papers (2018–2020)Ajit Shah · MBC BioLabs (United States)2 papers (2019–2021)Michael Kohn · Stanford Medicine2 papers (2024–2026)Robert J Rushakoff · University of California San Francisco Medical Center2 papers (2024–2026)Trisha Shang · Case Western Reserve University2 papers (2021–2022)Jennifer Y. Zhang · Kaiser Permanente2 papers (2021–2022)Atul J. Butte · Directorate-General for Interpretation2 papers (2025–2025)David Kerr · Diabetes Technology Society2 papers (2022–2025)David Lutrin · University of California, San Francisco2 papers (2017–2018)